Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Leiras claims oral delivery system for oxybutynin chloride

July 26, 1996

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

July 26, 1996

Positive results in trial of Cystistat in refractory interstitial cystitis patients

July 19, 1996

CGP-53153: Ciba-Geigy's steroidal 5alpha-reductase inhibitor as BPH therapy

July 19, 1996

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Cystistat covered under U.S. patent

July 12, 1996

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

Flutamide BPH trial results reported

July 5, 1996

Abbott reports alpha1-antagonists for BPH

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...